| Literature DB >> 20011463 |
Ruhul Amin1, Hasan Jamil, M Anwar Hossain.
Abstract
Melanoma antigen family (MAGE) genes are widely expressed in various tumor types but silent in normal cells except germ-line cells lacking human leukocyte antigen (HLA) expression. Over 25 MAGE genes have been identified in different tissues, mostly located in Xq28 of human chromosome and some of them in chromosome 3 and 15, containing either single or multiple-exons. This in silico study predicted the genes on hTERT location and identified a distant relative of MAGE gene located on chromosome 5. The study identified a single exon coding ~850 residues polypeptide sharing ~30% homology with Macfa-MAGE E1 and hMAGE-E1. dbEST search of the predicted transcript matches 5' and 3' flanking ESTs. The predicted protein showed sequence homology within the MAGE homology domain 2 (MHD2). UCSC genome annotation of CpG Island around the coding region reveals that this gene could be silent by methylation. Affymetrix all-exon track indicates the gene could be expressed in different tissues particularly in cancer cells as they widely undergo a genome wide demethylation process.Entities:
Keywords: EST; ORF; gene prediction; melanoma antigen; telomerase
Year: 2009 PMID: 20011463 PMCID: PMC2791492 DOI: 10.4137/cin.s3392
Source DB: PubMed Journal: Cancer Inform ISSN: 1176-9351
Summary of the gene prediction analysis result of gene2 and gene3.
| Gene Prediction Program | Predicted Genes | Strand | Features | Start | End |
|---|---|---|---|---|---|
| Complement | Promoter | 9515 | 9476 | ||
| Initial exon | 9155 | 9102 | |||
| Internal exon | 7861 | 5671 | |||
| Terminal exon | 5518 | 5064 | |||
| Poly A site | 4718 | 4713 | |||
| Complement | Promoter | 16734 | 16116 | ||
| Initial exon | 16386 | 16116 | |||
| Internal exon | 14465 | 13849 | |||
| Terminal exon | 13831 | 12458 | |||
| Poly A site | 9749 | 9744 | |||
| Complement | CDS | 7869 | 5617 | ||
| Complement | CDS-1 | 14225 | 13860 | ||
| CDS-2 | 13689 | 12469 | |||
| Complement | TSS | 9618 | 9618 | ||
| Exon-1 | 7858 | 5606 | |||
| Poly A site | 4723 | 4723 | |||
| Complement | TSS | 16699 | 16699 | ||
| Exon-1 | 16195 | 16116 | |||
| Exon-2 | 13907 | 12458 | |||
| Poly A site | 11428 | 11428 | |||
| Complement | Exon-1 | 7858 | 5606 | ||
| Complement | Initial exon | 16386 | 16116 | ||
| Internal exon | 14465 | 13849 | |||
| Terminal exon | 13831 | 12458 | |||
| Complement | ORF in Frame-2 | 7858 | 5606 | ||
| Complement | ORF in Frame-3 | 13122 | 12106 |
Figure 1UCSC Genome Browser analysis showing the location of the predicted genes. Affymetrix All Exon Chip-Array tracks are used for tissue specific gene expression. CpG Island is also observed around the predicted gene.
Figure 2Conservation of gene2 in Chimpanzee (Pan troglodytes) and orangutan (Pongo pygmaeus-abelii) on VISTA browser.
Summary of the homologous sequences of predicted gene2.
| GI No. | Accession No. | Name of the protein | Length (aa) | Identity (%) | Similarity (%) | E-value |
|---|---|---|---|---|---|---|
| 67604778 | XP_666642.1 | Cell surface protein that may regulate cell wall beta-glucan synthesis and bud site selection | 999 | 27.76 | 48.53 | 2e-28 |
| 88602575 | YP_502753.1 | Mucin 2, intestinal/ | 2353 | 27.69 | 36.69 | 6e-26 |
| 66363458 | XP_628695.1 | Serine/threonine rich low complexity protein | 951 | 27.25 | 51.0 | 8e-23 |
| 71402846 | XP_804287.1 | Cellulosomal scaffoldin anchoring protein | 928 | 40.67 | 44.33 | 2e-08 |
| 114771991 | ZP_01449380.1 | Fibronectin type III domain protein [alpha proteobacterium HTCC2255] | 2282 | 25.0 | 38.33 | 2e-08 |
| 52144448 | YP_082380.1 | Collagen-binding surface protein | 913 | 25.38 | 30.85 | 4e-08 |
| 50401145 | Q9BE18 | Melanoma-associated antigen E1 (MAGE-E1 antigen) Macfa | 957 | 28.0 | 41.0 | 5e-08 |
| 89095693 | ZP_01168587.1 | RTX toxins and related Ca2+-binding protein | 1415 | 23.33 | 38.0 | 1e-04 |
| 29792032 | AAH50588.1 | Melanoma antigen family E, 1 | 957 | 28.0 | 41.67 | 6e-04 |
| 118716717 | ZP_01569254.1 | Hemagluttinin domain protein [ | 1487 | 25.4 | 50.0 | 0.004 |
Figure 3Global alignment of gene2 with MAGE homology domain (MHD).
Repeated sequence motif of the predicted gene2 analyzed by RADAR.
Figure 4Secondary structure prediction of gene2 using HNN.
Comparative function prediction of MAGE-E1 and gene2 using SVMProt.
| MAGE-E1 | |||
|---|---|---|---|
| Function | P Value (%) | Function | P Value (%) |
| Zinc-binding | 73.8 | Zinc-binding | 58.6 |
| Nuclear receptors | 65.4 | Metal-binding | 58.6 |
| EC 3.4 Hydrolases—Acting on peptide bonds (Peptidases) | 58.6 | ||
| Calcium-binding | 58.6 | ||
| TC 1.B. Channels/Pores—Beta-Barrel porins | 58.6 | ||
Comparative function prediction of MAGE-E1 and Gene2 using PFP.
| MAGE-E1 | |||
|---|---|---|---|
| GO.0008347 glia cell migration | 2907203.66 | GO.0009405 pathogenesis | 760364.22 |
| GO.0048011 nerve growth factor receptor signaling pathway | 1164048.92 | GO.0008380 RNA splicing | 539421.38 |
| GO.0019233 perception of pain | 961041.64 | GO.0000398 nuclear mRNA splicing, via spliceosome | 380866.18 |
| GO.0001764 neuronal migration | 868699.27 | GO.0007520 myoblast fusion | 365931.67 |
| GO.0042060 wound healing | 500313.41 | GO.0007399 neurogenesis | 222373.08 |
| GO.0000074 regulation of cell cycle | 473884.91 | GO.0006512 ubiquitin cycle | 205861.13 |
| GO.0001558 regulation of cell growth | 367704.56 | GO.0016574 histone ubiquitination | 205248.68 |
| GO.0007585 respiratory gaseous exchange | 316119.23 | GO.0006816 calcium ion transport | 187647.36 |
| GO.0009062 fatty acid catabolism | 263724.05 | GO.0008104 protein localization | 177700.20 |
| GO.0007420 brain development | 263045.24 | GO.0042110 T-cell activation | 171905.85 |
| GO.0043015 gamma-tubulin binding | 550081.62 | GO.0004308 exo-alpha-sialidase activity | 285616.06 |
| GO.0016798 hydrolase activity, acting on glycosyl bonds | 462333.96 | GO.0046982 protein heterodimerization activity | 258717.67 |
| GO.0004308 exo-alpha-sialidase activity | 451789.12 | GO.0008332 low voltage-gated calcium channel activity | 205987.38 |
| GO.0004445 inositol-polyphosphate 5-phosphatase activity | 222224.77 | GO.0016874 ligase activity | 190741.51 |
| GO.0005515 protein binding | 154771.23 | GO.0030215 semaphorin receptor binding | 161852.12 |
| GO.0004674 protein serine/threonine kinase activity | 132065.84 | GO.0008168 methyltransferase activity | 125300.40 |
| GO.0003968 RNA-directed RNA polymerase activity | 126483.06 | GO.0004568 chitinase activity | 112219.51 |
| GO.0008289 lipid binding | 119001.75 | GO.0042809 vitamin D receptor binding | 90949.14 |
| GO.0017016 Ras interactor activity | 106852.28 | GO.0004842 ubiquitin- protein ligase activity | 87944.78 |
| GO.0004806 triacylglycerol lipase activity | 105189.12 | GO.0004445 inositol-polyphosphate 5-phosphatase activity | 73545.05 |
| GO.0045211 postsynaptic membrane | 1992254.90 | GO.0030425 dendrite | 561550.58 |
| GO.0030425 dendrite | 811128.08 | GO.0009986 cell surface | 229447.45 |
| GO.0016010 dystrophin-associated glycoprotein complex | 493386.26 | GO.0005891 voltage-gated calcium channel complex | 220997.24 |
| GO.0005813 centrosome | 380800.79 | GO.0005681 spliceosome complex | 151073.10 |
| GO.0048471 perinuclear region | 276406.16 | GO.0015629 actin cytoskeleton | 125368.18 |
| GO.0015629 actin cytoskeleton | 178410.28 | GO.0005737 cytoplasm | 63162.21 |
| GO.0046581 intercellular canaliculus | 172680.03 | GO.0016010 dystrophin-associated glycoprotein complex | 58828.49 |
| GO.0005634 nucleus | 150265.62 | GO.0005615 extracellular space | 53737.16 |
| GO.0005925 focal adhesion | 136189.60 | GO.0005643 nuclear pore | 47225.56 |